Carna Biosciences, Inc. (4572.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.8B |
| Enterprise Value | 7B |
| P/E Ratio | -3.83 |
| PEG Ratio | -1.92 |
| Price/Sales Ratio | 11.24 |
| Price/Book Ratio | -20.93 |
| Enterprise/Revenue | 12.45 |
| Enterprise/EBITDA | -4.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.96 |
| Operating Margin | -2.71 |
AD
Management Effectiveness
| Return On Assets | -1.22 |
| Return On Equity | -14.32 |
Income Statement
| Revenue | 579.06M |
| Revenue/Share | 36.48 |
| Gross Profit | 388.15M |
| EBITDA | -2.16B |
| Net Income | -2.17B |
| Diluted EPS | -113.62 |
Balance Sheet
| Total Cash | 1.1B |
| Total Cash/Share | 55.05 |
| Total Debt | 1.99B |
| Total Debt/Equity | -4.87 |
| Current Ratio | 12.08 |
| Book Value Per Share | -20.4 |
Price History
| 52-Week Change | 93.21 |
| 52-Week High | 512 |
| 52-Week Low | 200 |
| Moving Average 50 Days | 356.96 |
| Moving Average 200 Days | 367.8 |
Statistics
| Average Volume | 151,334 |
| Shares Outstanding | 19.19M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 100:1 |
| Last Split Date | December 26, 2013 |
AD
